Every story here starts with a document.
A drug label or a court record, quoted word for word.
Earlier articles
Suspected Fake Semaglutide: 89% of Reports Were Serious
Researchers pulled 234 European reports of suspected fake semaglutide. 89.3% were serious, and low blood sugar showed up far more often. See the numbers.
Checked · 1 source · 4 min read
The Peptide Plan Is Public. It Approves Nothing.
On 28 October 2026 HHS published its peptide compounding policy. It covers six peptides, sets ten conditions and approves nothing. Here is what it says.
Checked · 7 sources · 5 min read
Sold as Retatrutide. The Lab Found Semaglutide Instead.
Australian officials linked six liver injuries to products labelled retatrutide. A lab tested one vial and found no retatrutide in it. See what it held.
Checked · 2 sources · 4 min read
Is Mounjaro Making Your Birth Control Fail?
Mounjaro's own leaflet says birth control pills may not work as well, and that nobody knows if the drug harms an unborn baby. See the numbers behind it.
Checked · 8 sources · 5 min read
6 No-Prescription Semaglutide Orders. Only 3 Showed Up.
Researchers ordered semaglutide from six no-prescription websites. Three orders were scams. Three arrived at 7% to 14% purity. See what the lab found.
Checked · 3 sources · 5 min read
A Peptide Seller Got 70 Months. Who Made Your Lab Report?
Fake peptide COA? Prosecutors say a seller with more than 54,000 customers edited other firms' lab certificates. Their memo reports no test of a peptide.
Checked · 3 sources · 5 min read
The Wednesday email
New articles go out in the Wednesday email, with the documents they quote.